COLLABORATE El Meu Clínic .This link opens in a new tab.
COLLABORATE El Meu Clínic .This link opens in a new tab.
Navigation thread
Navigation thread
Immunogenomics and evolution of lymphoid neoplasms

Featured projects

  • Deciphering the life histories of chronic lymphocytic leukemia to improve clinical outcome (CLL-STORY)

    Principal investigator: Ferran Nadeu Prat.
    Funder: European Research Council (ERC).
    Code: 101222226.
    Duration: 01/01/2026 - 31/12/2030

  • Contrato Miguel Servet 2025

    Principal investigator: Ferran Nadeu Prat.
    Funder: Instituto de Salud Carlos III.
    Code: CP25/00084.
    Duration: 01/01/2026 - 31/12/2030

  • Caracterización de la evolución clonal y las interacciones del microambiente que dictan la progresión de la leucemia linfocítica crónica y la transformación de Richter

    Principal investigator: Ferran Nadeu Prat.
    Funder: Fundacion Espanola de Hematologia y Hemoterapia (FEHH).
    Code: FEHH_BECAS24_01.
    Duration: 01/01/2025 - 31/12/2025

  • Genomic and transcriptomic diversification driving resistance to CAR-T cell therapy in mantle cell lymphoma

    Principal investigator: Ferran Nadeu Prat.
    Funder: Gilead.
    Code: GLD23_00086.
    Duration: 30/01/2024 - 29/01/2026

  • Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

    Principal investigator: Ferran Nadeu Prat.
    Funder: European Hematology Association (EHA).
    Code: EHA Junior Research Grant 2021 (RG-202012-00245).
    Duration: 01/01/2022 - 31/12/2024

  • Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints

    Principal investigator: Ferran Nadeu Prat.
    Funder: Lady Tata Memorial Trust.
    Code: International Award for Research in Leukaemia 2021-2022 (LADY_TATA_21_3223).
    Duration: 01/10/2021 - 30/09/2022

  • Tracking the progression and transformation of chronic lymphocytic leukemia

    Principal investigator: Ferran Nadeu Prat.
    Funder: American Association for Cancer Research (AACR).
    Code: American Association for Cancer Research (AACR)-Amgen Fellowship in Clinical/Translational Cancer Research (21-40-11-NADE).
    Duration: 01/07/2021 - 30/06/2023

Major founders

The research of this group can be carried out thanks to the funders.